Pioneering therapies for people with neurological disorders

Our Vision

Patient-focused, science-backed, our mission is to develop life-changing treatment options for people with neuropsychiatric or neurodegenerative disorders

Novel Mechanism of Action, New class of therapies

20 years of studying regulation of synaptic density and function led us to identify intracellular magnesium as a critical second messenger controlling synaptic function and plasticity.

Unique approach to promote
synaptogenesis and enhance synaptic function

Through molecular screening, we identified a novel compound that can selectively elevate intracellular magnesium at the synaptic terminal. In vivo, this compound increases synaptic density, function, and plasticity, and improves learning and memory.